Cancer pain syndromes and pharmacotherapy of cancer pain

Archive of Oncology

Volumn 12, Issue 3, 2004, Pages 168-170

  Ripamonti, Carla ^a   Longo, Matteo ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Analgesics; Drug therapy; Neoplasms; Pain

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; CODEINE; CORTICOSTEROID; DESIPRAMINE; DEXAMETHASONE; FENTANYL CITRATE; GABAPENTIN; HYDROMORPHONE; IMIPRAMINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PHENYTOIN; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ANALGESIA; ATAXIA; BONE MARROW DEPRESSION; BONE METASTASIS; CANCER INFILTRATION; CANCER INVASION; CANCER PAIN; CANCER THERAPY; CONFERENCE PAPER; CONFUSION; CONSTIPATION; DIPLOPIA; DRUG DOSE REGIMEN; DRUG EFFECT; HALLUCINATION; HERPES ZOSTER; HUMAN; LIVER DYSFUNCTION; MYOCLONUS; NAUSEA AND VOMITING; NEUROPATHIC PAIN; ORTHOSTATIC HYPOTENSION; POSTOPERATIVE PAIN; SEDATION; SOMNOLENCE; SUSTAINED RELEASE FORMULATION; XEROSTOMIA;

EID: 8144230226     PISSN: 03547310     EISSN: None     Source Type: Journal    
DOI: 10.2298/AOO0403168R     Document Type: Conference Paper

References (12)

1. Campa III JA, Payne R. Pain syndromes due to cancer treatment In: Cancer Pain. Patt R, editors. Philadelphia: J.B. Lippincott Company; 1993; p. 41-56.
2. Foley KM. Acute and chronic cancer pain syndromes. In: Doyle D, Hanks G, Chemy N, Calman K, editors. Oxford Textbook of Palliative Medicine, 3rd ed. Oxford University Press; 2004. p. 298-316.
3. Portenoy RK, Conn M. Cancer pain syndromes. In: Bruera E, Portenoy RK, editors. Cancer pain. Assessment and management. Cambridge University Press; 2003. p. 89-108.
4. Berenson JJ, Hillner BE, Kyle RA et al. American Society of Clinical Oncology Clinical Practice Guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 2002;20:3719-36.
5. Berenson JR, Rosen LS, Howell A et al. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. A double-blind, randomized dose-response study. Cancer 2001;91:1191-200.
6. Byrne TN. Spinal cord compression from epidural metastases. N Engl J Med 1992;327(9):614-9.
7. Dickman A, Ellershaw J. NSAIDs: gastroprotection or selective COX-2 inhibitor? Palliative Medicine 2004;18:275-86.
8. Ripamonti C. Pharmacology of opioid analgesia: clinical principles. In: Bruera E, Portenoy RK, editors. Cancer pain. Assessment and management. Cambridge University Press; 2003;8:124-243.
9. Hanks GW, De Conno F, Cherny N et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Expert Working Group of the Research Network of the European Association for Palliative Care. Br J Cancer 2001;84(5):587-93.
10. Ripamonti C, Bianchi M. The use of methadone for cancer pain. Hematology Oncology Clinics of North America 2002;16:543-55.
11. Ripamonti C, Dickerson ED. Strategies for the treatment of cancer pain in the New Millennium. Drugs 2001;61(7):955-77.
12. Caraceni A, Zecca E, Bonezzi C et al. Gabapentin for neuropathic pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 2004;22(14):2909-17.